Stocksigma LogoStocksigma Logo

Vivo Bio Tech Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lacs)

■ Revenue: 1,719 (+31.1% YoY | +20.4% QoQ) ■ EBITDA: 608 (+12.4% YoY | +20.4% QoQ) ■ EBITDA Margin (%): 35.4 (-590 bps YoY | +0 bps QoQ) ■ PAT: 110 (+26.9%

Vivo Bio Tech Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lacs)

Vivo Bio Tech Ltd · Outcome · 12 Nov 2026, 12:46 am

Vivo Bio Tech Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lacs) ■ Revenue: 1,719 (+31.1% YoY | +20.4% QoQ) ■ EBITDA: 608 (+12.4% YoY | +20.4% QoQ) ■ EBITDA Margin (%): 35.4 (-590 bps YoY | +0 bps QoQ) ■ PAT: 110 (+26.9% YoY | +487.5% QoQ) ■ EPS (INR): 0.50 (+11.1% YoY | +525.0% QoQ)

Original exchange filing (PDF)

More announcements from Vivo Bio Tech Ltd

All Vivo Bio Tech Ltd announcements